Tourbillon Capital Partners’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-515,816
Closed -$7.87M 47
2018
Q2
$7.87M Buy
+515,816
New +$8.92M 0.3% 62
2016
Q1
Sell
-514,648
Closed -$12.4M 75
2015
Q4
$12.4M Sell
514,648
-72,193
-12% -$1.81M 0.28% 55
2015
Q3
$14.4M Sell
586,841
-313,159
-35% -$8.87M 0.38% 59
2015
Q2
$21.1M Buy
900,000
+125,000
+16% +$2.72M 0.46% 62
2015
Q1
$17.4M Buy
+775,000
New +$14.9M 0.45% 52

Other funds holding DVAX

Tourbillon Capital Partners's DVAX Position: Q3 2018 in Review

Tourbillon Capital Partners sold out of Dynavax Technologies (DVAX) in Q3 2018, closing a stake of 515,816 shares — an estimated $7.87M sold.

Tourbillon Capital Partners first reported a position in DVAX in Q1 2015 and held it in 5 quarters. The position peaked at $21.1M in Q2 2015. 150 funds tracked by Wall St. Rank hold DVAX as of Q3 2018.

  • Tourbillon Capital Partners reported no remaining Dynavax Technologies position as of Q3 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 515,816 Dynavax Technologies shares in Q3 2018, an estimated $7.87M.
  • Tourbillon Capital Partners first reported a position in Dynavax Technologies in Q1 2015 and held it in 5 quarters.
  • Tourbillon Capital Partners's Dynavax Technologies position peaked at $21.1M in Q2 2015.
  • 150 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2018.

Based on Tourbillon Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.